http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016163912-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08387c7f1a7b697d85d1e2c576596516
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-04
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-503
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1866
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
filingDate 2015-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e56d828fedeae374e039f0d59d6c4c91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7918a2bfa376f44bfd78195104f61fbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ac755e8d4b7f590d22fb9df81a09ef8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_891582548b05de792ed30352ebaa9fb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84f539b05042b276c13c1efd66ad7a75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a8b749f4d13aa9db521d913fc6660de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_029add65fd0cfb6f8925a7c31af83b25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_866fdf95ffb1dbd789f88b0f6e89d84a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d31f650eae547ec991d18dec75894c0c
publicationDate 2016-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016163912-A1
titleOfInvention Codon-optimized recombinant plasmid, method of stimulating peripheral nerve regeneration, and method of treating nerve damage in humans
abstract The invention relates to medicine, and more particularly to neurosurgery and trauma surgery, and can be used for stimulating nerve regeneration through the use of a gene therapeutic construct which codes for vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF-2). The gene therapeutic construct that codes for the two factors is based on a codon-optimized recombinant plasmid. The gene therapeutic construct can be introduced either directly into a damaged nerve or into the perineural tissues either during surgery or in the post-operative period. The invention significantly improves the outcomes of the reconstructive treatment of damaged peripheral nerves.
priorityDate 2014-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1732614-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2517117-C2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300

Total number of triples: 39.